Condition: Parkinson Disease · Sponsor: Northwestern University
This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax or 2)80-85% HRmax 4 times per week. The primary objective is to test whether the progression of the signs of Parkinson's disease is attenuated at 12 months in among persons who have not initiated medication for Parkinson Disease (PD) when they perform high-intensity endurance treadmill exercise.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| University of Colorado, Denver | Aurora, Colorado, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| Morehouse School of Medicine | Atlanta, Georgia, United States | — |
| Emory University | Atlanta, Georgia, United States | — |
| Northwestern University | Chicago, Illinois, United States | — |
| Rush University Medical Center | Chicago, Illinois, United States | — |
| Iowa State University | Ames, Iowa, United States | — |
| Louisiana State University | Baton Rouge, Louisiana, United States | — |
| Boston University (Charles River Campus) | Boston, Massachusetts, United States | — |
| University of Michigan | Ann Arbor, Michigan, United States | — |
+ 13 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.